Table 3. Comparison of classification performance using identified FFLs.

Data	ACC	SN	SP	MCC
Baseline	71.2%	86.5%	10.7%	−0.033
Normal prostate FFLs	95.0%	96.4%	89.3%	0.846
Prostate cancer FFLs	95.7%	97.3%	89.3%	0.866
All FFLs	97.1%	99.1%	89.3%	0.909